BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The offering is being made pursuant to a shelf registration statement on Form S-3 (File No. 333-276298) declared effective by the SEC.
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
Proposed Public Offering
BioSig intends to use the net proceeds to purchase gold bullion, for working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are managing the offering.
- The completion of the offering remains subject to market conditions with no assured timing, size, or terms.
- Interested parties should read the preliminary prospectus supplement and accompanying base prospectus before investing.
BioSig Technologies Inc. is moving forward with a proposed public offering to fund strategic initiatives and corporate operations.